Feed 6160.HK
61
BeOne Medicines AG
6160.HK · HKSE
$211.20 -3.74% (-$8.20)
1M +10.69%
Market Cap $37.2B
P/E Ratio 129.40x
Div. Yield -
ROE 7.11%
Bulios Fair Price
$259.57
22.9% upside
Trenutna cena
$211.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica 6160.HK trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Valuation
9 /100
Expensive P/E 129.40x
P/B 8.53x
EV/EBITDA 57.13x
Growth
83 /100
Growing Rev. growth 55.76%
Book val. growth 0.17%
EPS growth N/A
Profitability
68 /100
Strong Gross margin 85.28%
FCF margin 17.63%
Net margin 5.37%
Quality
33 /100
Poor ROIC 4.78%
Asset turnover 0.65x
ROE 7.11%
Debt
95 /100
Low Debt/Equity 0.25x
Net debt/EBITDA -5.93x
Current ratio 3.41x
Stability
49 /100
Moderate Beta 0.50x
Profitable years 1
Rev. volatility 16.65%
Vprašajte StockBota o 6160.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John V. Oyler
Employees
12,000
Headquarters
Basel
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report